Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

185 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparative study of the detection of joint injury in early-stage rheumatoid arthritis by magnetic resonance imaging of the wrist and finger joints and physical examination.
Tamai M, Kawakami A, Iwamoto N, Kawashiri SY, Fujikawa K, Aramaki T, Kita J, Okada A, Koga T, Arima K, Kamachi M, Yamasaki S, Nakamura H, Ida H, Origuchi T, Takao S, Aoyagi K, Uetani M, Eguchi K. Tamai M, et al. Among authors: kita j. Arthritis Care Res (Hoboken). 2011 Mar;63(3):436-9. doi: 10.1002/acr.20395. Epub 2010 Nov 15. Arthritis Care Res (Hoboken). 2011. PMID: 21080353 Free article.
Treatment discontinuation in patients with very early rheumatoid arthritis in sustained simplified disease activity index remission after synthetic disease-modifying anti-rheumatic drug administration.
Kita J, Tamai M, Arima K, Nakashima Y, Suzuki T, Kawashiri SY, Iwamoto N, Okada A, Koga T, Yamasaki S, Nakamura H, Origuchi T, Ida H, Aoyagi K, Uetani M, Eguchi K, Kawakami A. Kita J, et al. Mod Rheumatol. 2012 Jun;22(3):346-52. doi: 10.1007/s10165-011-0522-8. Epub 2011 Sep 30. Mod Rheumatol. 2012. PMID: 21960457
Significant improvement in MRI-proven bone edema is associated with protection from structural damage in very early RA patients managed using the tight control approach.
Kita J, Tamai M, Arima K, Kawashiri SY, Horai Y, Iwamoto N, Okada A, Koga T, Nakashima Y, Suzuki T, Yamasaki S, Nakamura H, Origuchi T, Ida H, Aoyagi K, Uetani M, Eguchi K, Kawakami A. Kita J, et al. Mod Rheumatol. 2013 Mar;23(2):254-9. doi: 10.1007/s10165-012-0646-5. Epub 2012 Jun 6. Mod Rheumatol. 2013. PMID: 22669596
Combination of MRI-detected bone marrow oedema with 2010 rheumatoid arthritis classification criteria improves the diagnostic probability of early rheumatoid arthritis.
Tamai M, Kita J, Nakashima Y, Suzuki T, Horai Y, Okada A, Koga T, Kawashiri SY, Iwamoto N, Ichinose K, Arima K, Yamasaki S, Nakamura H, Origuchi T, Uetani M, Fukushima A, Aoyagi K, Eguchi K, Kawakami A. Tamai M, et al. Among authors: kita j. Ann Rheum Dis. 2014 Dec;73(12):2219-20. doi: 10.1136/annrheumdis-2013-205074. Epub 2014 Sep 2. Ann Rheum Dis. 2014. PMID: 25182837 Free article. No abstract available.
Contribution of an adenine to guanine single nucleotide polymorphism of the matrix metalloproteinase-13 (MMP-13) -77 promoter region to the production of anticyclic citrullinated peptide antibodies in patients with HLA-DRB1*shared epitope-negative rheumatoid arthritis.
Iwamoto N, Kawakami A, Arima K, Tamai M, Nakamura H, Kawashiri SY, Kita J, Okada A, Koga T, Kamachi M, Yamasaki S, Ichinose K, Ida H, Origuchi T, Eguchi K. Iwamoto N, et al. Among authors: kita j. Mod Rheumatol. 2011 Jun;21(3):240-3. doi: 10.1007/s10165-010-0375-6. Epub 2010 Nov 26. Mod Rheumatol. 2011. PMID: 21107991
Delayed treatment with tumor necrosis factor inhibitors in incomplete responders to synthetic disease-modifying anti-rheumatic drugs shows an excellent effect in patients with very early rheumatoid arthritis with poor prognosis factors.
Kita J, Tamai M, Arima K, Nakashima Y, Suzuki T, Kawashiri SY, Okada A, Koga T, Yamasaki S, Nakamura H, Origuchi T, Aramaki T, Nakashima M, Fujikawa K, Tsukada T, Ida H, Aoyagi K, Uetani M, Eguchi K, Kawakami A. Kita J, et al. Mod Rheumatol. 2012 Apr;22(2):195-201. doi: 10.1007/s10165-011-0511-y. Epub 2011 Sep 6. Mod Rheumatol. 2012. PMID: 21898075 Clinical Trial.
Soluble urokinase plasminogen activator receptor as a useful biomarker to predict the response to adalimumab in patients with rheumatoid arthritis in a Japanese population.
Koga T, Okada A, Kawashiri S, Kita J, Suzuki T, Nakashima Y, Tamai M, Satoh K, Origuchi T, Iwamoto N, Yamasaki S, Nakamura H, Migita K, Ida H, Ueki Y, Eguchi K, Kawakami A. Koga T, et al. Among authors: kita j. Clin Exp Rheumatol. 2011 Sep-Oct;29(5):811-5. Epub 2011 Oct 31. Clin Exp Rheumatol. 2011. PMID: 22011479 Clinical Trial.
Magnetic resonance imaging of wrist and finger joints distinguishes secondary Sjögren's syndrome with rheumatoid arthritis from primary Sjögren's syndrome with articular manifestations.
Iwamoto N, Kawakami A, Tamai M, Arima K, Nakamura H, Kawashiri SY, Kita J, Okada A, Koga T, Kamachi M, Yamasaki S, Ichinose K, Ida H, Origuchi T, Uetani M, Eguchi K. Iwamoto N, et al. Among authors: kita j. Clin Exp Rheumatol. 2011 Nov-Dec;29(6):1062-3. Epub 2011 Dec 22. Clin Exp Rheumatol. 2011. PMID: 22132779 No abstract available.
Magnetic Resonance Imaging Bone Edema at Enrollment Predicts Rapid Radiographic Progression in Patients with Early RA: Results from the Nagasaki University Early Arthritis Cohort.
Nakashima Y, Tamai M, Kita J, Michitsuji T, Shimizu T, Fukui S, Umeda M, Nishino A, Suzuki T, Horai Y, Okada A, Nishimura T, Koga T, Kawashiri SY, Iwamoto N, Ichinose K, Hirai Y, Arima K, Yamasaki S, Nakamura H, Origuchi T, Takao S, Uetani M, Aoyagi K, Eguchi K, Kawakami A. Nakashima Y, et al. Among authors: kita j. J Rheumatol. 2016 Jul;43(7):1278-84. doi: 10.3899/jrheum.150988. Epub 2016 May 1. J Rheumatol. 2016. PMID: 27134251
185 results